ArticleAmerican journal of physiology. Endocrinology and metabolism2025

A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic

Nisha Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.